Hamlet BioPharma AB publ (XSAT:HAMLET B) 3-Month Share Buyback Ratio : 0.00% (As of Mar. 2025 )

View and export this data going back to 2015. Start your Free Trial

What is Hamlet BioPharma AB publ 3-Month Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Hamlet BioPharma AB publ's current 3-Month Share Buyback Ratio was 0.00%.

Competitive Comparison of Hamlet BioPharma AB publ's 3-Month Share Buyback Ratio

For the Biotechnology subindustry, Hamlet BioPharma AB publ's 3-Month Share Buyback Ratio, along with its competitors' market caps and 3-Month Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hamlet BioPharma AB publ's 3-Month Share Buyback Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hamlet BioPharma AB publ's 3-Month Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Hamlet BioPharma AB publ's 3-Month Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Hamlet BioPharma AB publ 3-Month Share Buyback Ratio Calculation

Hamlet BioPharma AB publ's 3-Month Share Buyback Ratio for the quarter that ended in Mar. 2025 is calculated as

3-Month Share Buyback Ratio	=	(Shares Outstanding (EOP) (Dec. 2024 )	-	Shares Outstanding (EOP) (Mar. 2025 ))	/	Shares Outstanding (EOP) (Dec. 2024 )
	=	(177.685	-	177.685)	/	177.685
	=	0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hamlet BioPharma AB publ (XSAT:HAMLET B) 3-Month Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Hamlet BioPharma AB publ 3-Month Share Buyback Ratio Related Terms

Hamlet BioPharma AB publ Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hamlet BioPharma AB publ (XSAT:HAMLET B) » Definitions » 3-Month Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

7ZT:Germany

Address

Klinikgatan 32, BMC D10, Lund, SWE, SE-222 42

Website

http://www.hamletpharma.com

Hamlet BioPharma AB publ is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.

Hamlet BioPharma AB publ Headlines

No Headlines